🔎 Trials Near Me

Dachaigh › Aillse Prostata › Ohio › Cleveland

Sgrùdaidhean clionaigeach Aillse Prostata ann an Cleveland, OH

Tha 34 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann agus timcheall air Cleveland (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

The Vanguard Study: Testing a New Way to Screen for Cancer

A’ fastadhFàilte do shaor-thoilich fhallain
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06995898

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

A’ fastadhÌre 2
  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland Clinic Taussig Cancer Cente, Cleveland
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06738303

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

A’ fastadhÌre 1
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

A’ fastadhÌre 3
  • MetroHealth Medical Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Dàmh 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

A’ fastadhÌre 2
  • MetroHealth Medical Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06632977

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

A’ fastadh
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 28 Sult 2026 · NCT06496256

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

A’ fastadhÌre 1
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07319871

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

A’ fastadhÌre 3
  • University Hospitals Cleveland Medical Center ( Site 0043), Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06136650

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

A’ fastadhÌre 1
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Sult 2026 · NCT07082920

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

A’ fastadhÌre 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 mìle air falbh
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mìle air falbh
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Sult 2026 · NCT07028853

Investigation of Impact of AI on Prostate Cancer Workflow

A’ fastadh
  • Cleveland Clinic Foundation, Cleveland
Aoisean 55 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07084779

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

A’ fastadhÌre 2
  • University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 15 Sult 2026 · NCT06150417

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

A’ fastadh
  • University Hospitals Cleveland, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Sult 2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

A’ fastadhÌre 3
  • Case Western Reserve University, Cleveland
  • Louis Stokes Cleveland VA Medical Center, Cleveland
  • MetroHealth Medical Center, Cleveland
  • agus 5 a bharrachd
Aoisean 18 agus nas sine · Fir · Air ùrachadh 10 Sult 2026 · NCT05946213

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

A’ fastadhÌre 3
  • Research Site, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 26 Lùna 2026 · NCT07611110

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05919264

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

A’ fastadhÌre 2
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Lùna 2026 · NCT06842498

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

A’ fastadh
  • Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center, Cleveland
Aoisean 19 agus nas sine · Fir · Air ùrachadh 6 Lùna 2026 · NCT05610852

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

A’ fastadhÌre 3
  • Case Western Reserve University, Cleveland
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • agus 5 a bharrachd
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Iuch 2026 · NCT06592924

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

A’ fastadhSgrùdadh amharc
  • Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 7 Iuch 2026 · NCT07406282

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

A’ fastadhÌre 1
  • Cleveland Clinic Foundation, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Iuch 2026 · NCT07140900

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

A’ fastadhÌre 4
  • Cleveland Clinic Foundation, Cleveland
Aoisean 18 gu 100 · Fir · Air ùrachadh 4 Ògmh 2026 · NCT05803941

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

A’ fastadhÌre 1/2
  • University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 26 Cèit 2026 · NCT06574880

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

A’ fastadhSgrùdadh amharc
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 21 agus nas sine · Fir · Air ùrachadh 22 Cèit 2026 · NCT03151629

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

A’ fastadhÌre 1
  • Research Site, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 12 Cèit 2026 · NCT06879041

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

A’ fastadh
  • UH Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 4 Cèit 2026 · NCT05948657

Cleveland African American Prostate Cancer Project

A’ fastadhFàilte do shaor-thoilich fhallain
  • Barbershops Local to Cleveland, Cleveland
Aoisean 40 agus nas sine · Fir · Air ùrachadh 8 Gibl 2026 · NCT05469269

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

A’ fastadhÌre 2/3
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 8 Gibl 2026 · NCT04787744

Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

A’ fastadh
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 19 Gearr 2026 · NCT05590624

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Cleveland Clinic, Cleveland
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

A’ fastadhÌre 3
  • MetroHealth Medical Center, Cleveland
Aoisean 18 agus nas sine · Fir · Air ùrachadh 11 Sult 2025 · NCT03678025

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • Exelixis Clinical Site #7, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Sult 2025 · NCT05932862

Sgrùdaidhean Aillse Prostata ann am bailtean eile

Sgrùdaidhean eile ann an Cleveland

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.